Paper
12 January 1995 Clinical photodynamic therapy of malignant neoplasms
Eugeny Ph. Stranadko, Oleg K. Skobelkin, Gregory Litwin, Tamara A. Astrakhankina
Author Affiliations +
Proceedings Volume 2325, Photodynamic Therapy of Cancer II; (1995) https://doi.org/10.1117/12.199150
Event: International Symposium on Biomedical Optics Europe '94, 1994, Lille, France
Abstract
The analysis of the results of treatment of 379 malignant neoplasms with PDT in 89 patients has been made. Photogem (hematoporphyrin derivative) and Photosense (aluminum sulfonated derivative) -- both produced in Russia -- were used as photosensitizers. An argon-pumped dye- laser called `Innova 200' (Coherent USA), a Russian dye laser with copper vapor pumping (Yakhroma 2), a gold vapor laser (630 nm and 627.8 nm, accordingly) for Photogem, and a solid aluminate ittrium laser (672 nm) for Photosense were used. Up to now we have had follow-up control of 75 patients for the period of 2 months to 2.5 years. Positive effect of PDT was seen in 90.7% (68 out of 75); including complete regression -39 (52%), partial (50 - 100%), -in 29 (38.7%).
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Eugeny Ph. Stranadko, Oleg K. Skobelkin, Gregory Litwin, and Tamara A. Astrakhankina "Clinical photodynamic therapy of malignant neoplasms", Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); https://doi.org/10.1117/12.199150
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Photodynamic therapy

Bladder cancer

Lung cancer

Bladder

Tissue optics

Acquisition tracking and pointing

Back to Top